Original article| Volume 25, ISSUE 1, P22-27, January 2015

Download started.


Same-Day Intrauterine Device Placement is Rarely Complicated by Pelvic Infection

Published:November 25, 2014DOI:



      To compare rates of pelvic inflammatory disease (PID) among women who did and did not receive an intrauterine device (IUD) the day they sought emergency contraception (EC) or pregnancy testing.


      Women, 15 to 45 years of age, who sought EC or pregnancy testing from an urban family planning clinic completed surveys at the time of their clinic visit (August 22, 2011, to May 30, 2013) and 3 months after their clinic visit. The surveys assessed contraceptive use and symptoms, testing, and treatment for sexually transmitted infections (STI) and PID. We reviewed the medical records of participants who reported IUD placement within 3 months of enrollment and abstracted de-identified electronic medical record (EMR) data on all women who sought EC or pregnancy testing from the study clinic during the study period.


      During the study period, 1,060 women visited the study clinic; 272 completed both enrollment and follow-up surveys. Among survey completers with same-day IUD placement, PID in the 3 months after enrollment was not more common (1/28 [3.6%]; 95% CI, 0%–10.4%) than among women who did not have a same-day IUD placed (11/225 [4.9%]; 95% CI, 2.7%–8.6%; p = .71). Chart review and EMR data similarly showed that rates of PID within 3 months of seeking EC or pregnancy testing were low whether women opted for same-day or delayed IUD placement.


      Same-day IUD placement was not associated with higher rates of PID. Concern for asymptomatic STI should not delay IUD placement, and efforts to increase the uptake of this highly effective reversible contraception should not be limited to populations at low risk of STI.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Women's Health Issues
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bergin A.
        • Tristan S.
        • Terplan M.
        • Gilliam M.L.
        • Whitaker A.K.
        A missed opportunity for care: two-visit IUD insertion protocols inhibit placement.
        Contraception. 2012; 86: 694-697
        • Biggs M.A.
        • Arons A.
        • Turner R.
        • Brindis C.D.
        Same-day LARC insertion attitudes and practices.
        Contraception. 2013; 88: 629-635
        • Biggs M.A.
        • Harper C.C.
        • Malvin J.
        • Brindis C.D.
        Factors influencing the provision of long-acting reversible contraception in California.
        Obstetrics & Gynecology. 2014; 123: 593-602
      1. Centers for Disease Control and Prevention. (2011, February 27). Chlamydia profiles, 2011. Available: Accessed August 26, 2014.

        • Cheng L.
        • Che Y.
        • Gulmezoglu A.M.
        Interventions for emergency contraception.
        Cochrane Database of Systematic Reviews. 2012; 8: CD001324
        • Cleland K.
        • Zhu H.
        • Goldstuck N.
        • Cheng L.
        • Trussell J.
        The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience.
        Human Reproduction. 2012; 27: 1994-2000
        • Division of Reproductive Health
        • National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC)
        U.S. selected practice recommendations for contraceptive use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition.
        MMWR Recommendations and Reports. 2013; 62: 1-60
        • Farley T.M.
        • Rosenberg M.J.
        • Rowe P.J.
        • Chen J.H.
        • Meirik O.
        Intrauterine devices and pelvic inflammatory disease: an international perspective.
        Lancet. 1992; 339: 785-788
        • Faundes A.
        • Telles E.
        • Cristofoletti M.L.
        • Faundes D.
        • Castro S.
        • Hardy E.
        The risk of inadvertent intrauterine device insertion in women carriers of endocervical Chlamydia trachomatis.
        Contraception. 1998; 58: 105-109
        • Finer L.B.
        • Jerman J.
        • Kavanaugh M.L.
        Changes in use of long-acting contraceptive methods in the United States, 2007-2009.
        Fertility & Sterility. 2012; 98: 893-897
        • Harper C.C.
        • Henderson J.T.
        • Raine T.R.
        • Goodman S.
        • Darney P.D.
        • Thompson K.M.
        • et al
        Evidence-based IUD practice: Family physicians and obstetrician-gynecologists.
        Family Medicine. 2012; 44: 637-645
        • Hladky K.J.
        • Allsworth J.E.
        • Madden T.
        • Secura G.M.
        • Peipert J.F.
        Women's knowledge about intrauterine contraception.
        Obstetrics & Gynecology. 2011; 117: 48-54
        • Hubacher D.
        • Fortney J.
        Follow-up visits after IUD insertion. Are more better?.
        Journal of Reproductive Medicine. 1999; 44: 801-806
        • Hubacher D.
        • Grimes D.A.
        • Gemzell-Danielsson K.
        Pitfalls of research linking the intrauterine device to pelvic inflammatory disease.
        Obstetrics & Gynecology. 2013; 121: 1091-1098
        • Hubacher D.
        • Lara-Ricalde R.
        • Taylor D.J.
        • Guerra-Infante F.
        • Guzman-Rodriguez R.
        Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women.
        New England Journal of Medicine. 2001; 345: 561-567
        • Mishell Jr., D.R.
        • Moyer D.L.
        Association of pelvic inflammatory disease with the intrauterine device.
        Clinical Obstetrics & Gynecology. 1969; 12: 179-197
        • Mohllajee A.P.
        • Curtis K.M.
        • Peterson H.B.
        Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review.
        Contraception. 2006; 73: 145-153
        • Morrison C.S.
        • Turner A.N.
        • Jones L.B.
        Highly effective contraception and acquisition of HIV and other sexually transmitted infections.
        Best Practice & Research Clinical Obstetrics & Gynaecology. 2009; 23: 263-284
        • Schwarz E.B.
        • Papic M.
        • Parisi S.M.
        • Baldauf E.
        • Rapkin R.
        • Updike, G
        Routine counseling about intrauterine contraception for women seeking emergency contraception.
        Contraception. 2014; 90: 66-71
        • Singh S.
        • Sedgh G.
        • Hussain R.
        Unintended pregnancy: worldwide levels, trends, and outcomes.
        Studies in Family Planning. 2010; 41: 241-250
        • Sufrin C.B.
        • Postlethwaite D.
        • Armstrong M.A.
        • Merchant M.
        • Wendt J.M.
        • Steinauer J.E.
        Neisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease.
        Obstetrics & Gynecology. 2012; 120: 1314-1321
        • Swartzendruber A.
        • Sales J.M.
        • Brown J.L.
        • Diclemente R.J.
        • Rose E.S.
        Correlates of incident Trichomonas vaginalis infections among African American female adolescents.
        Sexually Transmitted Diseases. 2014; 41: 240-245
        • Sweet R.L.
        Pelvic inflammatory disease: Current concepts of diagnosis and management.
        Current Infectious Disease Reports. 2012;
        • Trussell J.
        Contraceptive failure in the United States.
        Contraception. 2011; 83: 397-404
      2. United Nations Department of Economic and Social Affairs, Population Division. (2011). World contraceptive use 2011. Available: Accessed October 8, 2014.


      Melissa Papic, BS, is a Data Manager in the Department of Epidemiology at the University of Pittsburgh. Her research interests include women's health, and maternal and child health research.


      Nan Wang, BS, is a Medical Student at the University of Pittsburgh School of Medicine.


      Sara M. Parisi, MS, MPH, is a Data Analyst in the Department of Epidemiology at the University of Pittsburgh. Her research interests include women's health, and maternal and child health research.


      Erin Baldauf, MEd, is a Research Coordinator at the Center for Research on Health Care at the University of Pittsburgh. Her research interests include women's health research.


      Glenn Updike, MD, is the Medical Director at the Magee-Womens Hospital Outpatient Clinic; and Assistant Professor in the Department of Obstetrics, Gynecology, & Reproductive Sciences at the University of Pittsburgh. His research interests include women's health research.


      Eleanor Bimla Schwarz, MD, MS, is a Professor of Medicine at the University of California, Davis. Her research interests include women's health, and maternal and child health research.